News Quantified

ALT – altimmune, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Altimmune announces CEO transition [Seeking Alpha]

Altimmune Announces CEO Transition and Succession Plan

Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]

Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference

Altimmune (NASDAQ:ALT) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..

4.2%

BEAT

2.9%

BEAT

-3.7%

BEAT

5.8%

BEAT

Market Outperform

Market Outperform

Form 4 Altimmune, Inc. For: Dec 01 Filed by: Durso Jerome Benedict

Form 8-K Altimmune, Inc. For: Nov 30

Form 4 Altimmune, Inc. For: Nov 11 Filed by: WEAVER GREGORY L

Form S-3 Altimmune, Inc.

Form 8-K Altimmune, Inc. For: Nov 06

Top News Gainers

2/28 Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine 29.8%

3/4 Altimmune (ALT) Presenta At Cowen Health Care Conference - Slideshow [Seeking Alpha] 18.2%

3/27 Form 8-K Altimmune, Inc. For: Mar 27 7.5%

6/12 Form 8-K Altimmune, Inc. For: Jun 10 5.5%

2/4 Form 4 Altimmune, Inc. For: Jan 31 Filed by: Roberts M Scot 3.4%

5/15 Altimmune, Inc. (ALT) CEO Vipin Garg on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 1.9%

11/21 Altimmune to Host Key Opinion Leader Call on ALT-801 for the Treatment of NASH 1.8%

4/8 Form 8-K Altimmune, Inc. For: Apr 02 1.8%

6/12 Altimmune Appoints Will Brown as Chief Financial Officer 1.7%

8/14 Form S-8 Altimmune, Inc. 1.5%

Top News Decliners

3/9 Thinking about buying stock in Aurora Cannabis, Altimmune, Chesapeake Energy Corp, Nokia, or Sprint? -20.8%

7/9 Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio -14.2%

3/30 Altimmune and the University of Alabama at Birmingham to Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine -13.7%

3/27 Form 8-K Altimmune, Inc. For: Mar 27 -13.4%

1/23 Altimmune Announces Positive Results for ALT-702 in Preclinical Model of Colorectal Cancer -12.6%

3/3 Form 4 Altimmune, Inc. For: Feb 29 Filed by: Garg Vipin K -12.0%

8/21 Form 8-K Altimmune, Inc. For: Aug 20 -11.7%

11/13 Altimmune Announces Third Quarter 2019 Financial Results and Provides a Business Update -10.1%

6/10 Altimmune Announces Successful Pre-IND Meeting with FDA -10.0%

6/5 Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs -9.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day